vadimezan has been researched along with phenylbutazone in 1 studies
| Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (phenylbutazone) | Trials (phenylbutazone) | Recent Studies (post-2010) (phenylbutazone) |
|---|---|---|---|---|---|
| 272 | 16 | 101 | 6,291 | 317 | 125 |
| Protein | Taxonomy | vadimezan (IC50) | phenylbutazone (IC50) |
|---|---|---|---|
| fMet-Leu-Phe receptor | Homo sapiens (human) | 5.3 | |
| Cyclooxygenase-2 | Canis lupus familiaris (dog) | 3.79 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baguley, BC; Jameson, MB; Kestell, P; Paxton, JW; Thompson, PI; Tingle, MD; Zhou, SF | 1 |
1 other study(ies) available for vadimezan and phenylbutazone
| Article | Year |
|---|---|
Identification and reactivity of the major metabolite (beta-1-glucuronide) of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplastic Agents; Chromatography, High Pressure Liquid; Diazepam; Dose-Response Relationship, Drug; GABA Modulators; Gas Chromatography-Mass Spectrometry; Glucuronidase; Glucuronides; Humans; Hydrogen-Ion Concentration; Hydrolysis; Male; Mice; Mice, Inbred C57BL; Models, Chemical; Phenylbutazone; Protein Binding; Rabbits; Rats; Rats, Wistar; Spectrometry, Mass, Electrospray Ionization; Time Factors; Warfarin; Xanthenes; Xanthones | 2001 |